Forest Lake, MN, United States of America

Matt Bergan

This inventor holds 2 USPTO granted patents. Top assignee: Medtronic, Inc.. Active years: 2012-2014.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matt Bergan: Innovator in Antimicrobial Compounds

Introduction

Matt Bergan is a notable inventor based in Forest Lake, MN (US). He has made significant contributions to the field of antimicrobial compounds, holding a total of 2 patents. His work focuses on enhancing the efficacy and stability of antimicrobial agents used in medical devices.

Latest Patents

Bergan's latest patents include innovative antimicrobial compounds that feature protective or therapeutic leaving groups. These compounds, such as silanol or alcohol, are designed to protect against degradation during the preparation of medical devices. The inclusion of a hydrolysable leaving group not only stabilizes the compound but may also serve a therapeutic function, enhancing the overall effectiveness of the antimicrobial agents.

Career Highlights

Matt Bergan is currently employed at Medtronic, Inc., a leading company in the medical technology sector. His work at Medtronic has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in medical device technology.

Collaborations

Bergan collaborates with talented professionals in his field, including Paul Hsien-Fu Wu and Catherine E. Taylor. These collaborations foster a creative environment that encourages the development of groundbreaking solutions in healthcare.

Conclusion

Matt Bergan's contributions to antimicrobial compounds demonstrate his commitment to innovation in medical technology. His patents reflect a deep understanding of the complexities involved in creating effective medical devices. His work continues to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…